Posted Mar. 14, 2017 at 7:07 a.m.

Premium Lock Chapel Hill drug firm Cempra puts itself up for sale

Published: 2017-03-14 07:07:56
Updated: 2017-03-14 07:07:56

Cempra Cempra Image 1 of 2 · Next Image…

​Clinical stag drug maker Cempra Inc. put itself up for sale on Monday, two weeks after it laid off two-third of its workers after Phase III results for one of its drugs came back disappointing....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2017 The University of North Carolina at Chapel Hill. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

page 1
sort order: oldest first | newest first
"...after it laid off two-third of its workers after Phase III results for one of its drugs came back disappointing."

I assume you mean the gonorrhea trial. That trial has only read out the first cohort. The data is not clear. They are going to do a dosage modification.

What about the Taksta trial which read out days before that was NOT "disappointing"?

But in any case, you could have worded it differently, because this is not why they laid off workers. They laid off workers because of the incompetent FDA.

http://seekingalpha.com/article/4044221-cempras-solithromycin-great-fda-echo-chamber
page 1
sort order: oldest first | newest first

Please Log In to add a comment.

Latest for Insiders